Jaishri Blakeley, MD
Brigatinib as treatment for NF2-schwannomatosis tumors
Nickhill Bhakta, MD, MPH
Minimizing global disparities in care
Andrew Davidoff, MD
Nephron sparing surgical approaches
Todd Gibson, PhD
Germline genetics and radiation-related subsequent cancer risk
Catherine Goudie, MD, FRPC
Development and implementation of the MIPOGG cancer predisposition syndrome screening tool
Othon Iliopolis, MD
Updates on VHL disease and its targeted therapy
Mary Louise Greer, MD, FRCR
Advanced imaging techniques in the evaluation of children with hereditary predisposition to cancer
Alyssa Kennedy, MD, PhD
Clonal hematopoiesis in patients with leukemia predisposition syndromes
Parvathy Krishna, MS, RD, CNSC
Living with CMMRD: Insights from a Parent-Caregiver Perspective
Erin Murphy, MD
Pediatric cranial radiosurgery
Leia NghiemPhu, MD, FAAN
Transition from pediatric to adult neurofibromatosis care
Tuya Pal, MD, FACMG
Increasing access to care delivery
Melissa Perrino, MD
Efficacy of surveillance across predisposition syndromes
Trevor Pugh, PhD, FACMG
Hereditary cancer surveillance using cell-free DNA sequencing
Katianne Howard Sharp, PhD
Psychosocial aspects of cancer genetic testing of children
Douglas Stewart, MD
The fault in our genes: quantifying cancer risk in rare pediatric disorders
Kenneth Tercyak, PhD, and Marcelo Sleiman Jr., BA, CPPN
Family communication about inherited cancer predisposition
Zhaoming Wang, PhD
Germline variation and survivor outcomes
Matthew Wilson, MD, FACS
The treatment of intraocular retinoblastoma